Answers are grounded in this paper and cite their sources.
Glioblastoma (GBM) is an aggressive brain tumor with a poor prognosis, frequently associated with TP53 mutations that impair the tumor suppressor function of p53. This study employed a comprehensive computational approach to investigate the structural and dynamic consequences of TP53 missense mutations in GBM. Using data from the GDC portal for variant identification and PolyPhen-2 for pathogenicity prediction, we analyzed mutation effects through conservation studies, stability predictions (DDMut), and molecular dynamics simulations (CABS-flex v2.0). Our analysis identified eleven destabilizing mutations (Y205S, I255S, I195T, Y205H, T256P, Y163C, P151H, R158H, T155P, R156G, and G266E) with predicted stability changes (ΔΔG ≤ -2.0 kcal mol-1), most located in the DNA-binding domain. Molecular dynamics simulations revealed distinct flexibility patterns, with Y205H showing the most significant deviation from wild-type p53, while Y163C maintained near-normal flexibility. Based on these findings, we propose a dynamics-based framework for TP53 variants according to their dynamic properties. These results demonstrate that TP53 mutations in GBM primarily affect protein stability and dynamics in the DNA-binding domain, likely contributing to oncogenesis through diverse mechanisms. This structural insight into p53 dysfunction in GBM provides a foundation for developing targeted therapeutic strategies against this devastating disease.
No takes yet. Share an insight, caveat, or question.
Hadi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: